Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice
E.P.K. Mensah‐Brown(United Arab Emirates University), Miodrag L. Lukić(University of Kragujevac), Z. Al Rabesi(United Arab Emirates University), Daniel K. Hsu(University of California, Davis), Nebojša Arsenijević(University of Kragujevac), F‐T Liu(University of California, Davis), Allen Shahin(United Arab Emirates University), Mariam Al Shamsi(United Arab Emirates University)
Cited by 95
Related Papers
IL-1 family nomenclature
|Nature Immunology|2010|341
Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
|International Journal of Cancer|2013|326
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304
Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
|Stem Cells|2010|286
IL-33/ST2 axis in inflammation and immunopathology
|Immunologic Research|2012|259